United States Newborn Screening Market

Market Overview:

United States newborn screening market size reached US$ 101.3 Million in ​2023​. Looking forward, IMARC Group expects the market to reach US$ 202.3 Million by ​2032​, exhibiting a growth rate (CAGR) of 7.90% during 2024-2032. The rising number of screening panels in the healthcare infrastructures, coupled with the elevating integration of digital technologies, is primarily propelling the market growth.

Newborn screening stands as a crucial public health initiative that is particularly designed to identify specific health conditions in infants shortly after birth. This essential process involves extracting a few drops of blood from the baby's heel, enabling the early identification of potentially severe conditions before any symptoms manifest. The scope of newborn screening encompasses the assessment of a diverse array of congenital disorders, metabolic irregularities, and genetic diseases. Beyond identification, this screening facilitates healthcare professionals in promptly implementing interventions and treatments, thus mitigating or preventing the adverse effects associated with these conditions. The significance of the process lies in its proactive approach, allowing for preemptive measures that can significantly impact the long-term health and well-being of newborns.

United States Newborn Screening Market Trends:

The United States newborn screening industry is experiencing significant growth, driven by the several factors and trends. Technological advancements play a pivotal role as next-generation sequencing and advanced molecular techniques enhance the precision and scope of newborn screening. These innovations contribute to the early detection of a broader range of genetic disorders, allowing for more targeted and personalized interventions. Additionally, the growing emphasis on expanding the newborn screening panel are notable trends. This expansion aligns with the overarching goal of newborn screening to provide timely interventions and improve health outcomes for infants. Furthermore, the elevating integration of data analytics and digital technologies is transforming newborn screening processes in the United States. Apart from this, the increasing use of artificial intelligence and machine learning enhances data interpretation, aiding healthcare professionals in making more informed decisions. It not only streamlines the screening process but also contributes to the development of more efficient and accurate diagnostic tools. Moreover, these drivers and trends underscore the commitment to advancing newborn healthcare, ensuring that infants receive timely and targeted interventions for a healthier start in life. This, in turn, is anticipated to fuel the market growth in the United States over the forecasted period.

United States Newborn Screening Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on product, technology, and test type.

Product Insights:

• Instruments
• Reagents
   

The report has provided a detailed breakup and analysis of the market based on the product. This includes instruments and reagents.

Technology Insights:

• Tandem Mass Spectrometry
• Pulse Oximetry
• Enzyme Based Assay
• DNA Assay
• Electrophoresis
• Others
   

A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes tandem mass spectrometry, pulse oximetry, enzyme based assay, DNA assay, electrophoresis, and others.

Test Type Insights:

• Dry Blood Spot Test
• CCHD
• Hearing Screen
   

The report has provided a detailed breakup and analysis of the market based on the test type. This includes dry blood spot test, CCHD, and hearing screen.

Regional Insights:

• Northeast
• Midwest
• South
• West
   

The report has also provided a comprehensive analysis of all the major regional markets, which include Northeast, Midwest, South, and West.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

United States Newborn Screening Market Report Coverage:

Key Questions Answered in This Report:

• How has the United States newborn screening market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the United States newborn screening market?
• What is the breakup of the United States newborn screening market on the basis of product?
• What is the breakup of the United States newborn screening market on the basis of technology?
• What is the breakup of the United States newborn screening market on the basis of test type?
• What are the various stages in the value chain of the United States newborn screening market? 
• What are the key driving factors and challenges in the United States newborn screening?
• What is the structure of the United States newborn screening market and who are the key players?
• What is the degree of competition in the United States newborn screening market?

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the United States newborn screening market from 2018-2032.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the United States newborn screening market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the United States newborn screening industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.